An application made for this job — a tailored resume and cover letter that speak straight to the posting.
AstraZeneca in Canada is recruiting for the Baselga Cancer Research Scholar, a two-year program designed for early-career oncologists. You will rotate through key oncology functions, gaining exposure to early and late clinical development with mentorship from senior experts.
The role emphasizes patient safety, data interpretation and cross‑functional collaboration, concluding in a longitudinal research project and possible publication.
At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.
Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office and BlueSky Hub in downtown Toronto are purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.
Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we’re taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention.
It is critical that we build and maintain our rich tradition of clinical expertise in support of developing life-changing medicines for patients.” –Jose Baselga
The Baselga Cancer Research Scholars Program, initiated in 2020, is a 2-year immersive education and research program for early-career Oncologists who are inspired by science and by how clinical development has the potential to transform patient care. As part of a competitively selected cohort of Scholars, you will join an accelerated development track within Oncology R&D. With individualized mentorship, there is opportunity to learn from a diverse group of experts across the drug development continuum, playing a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients’ lives. Selected Scholars will join the current cohort of Baselga Cancer Research Scholars, building a vibrant community of drug developers. We are currently recruiting for the 2027 class with an aim to start the position in summer‑autumn 2027.
Our Oncology strategy is built with one goal in mind – pushing the boundaries of science to deliver life-changing medicines to patients. We have a passion for discovery and a broad pipeline of next‑generation medicines, and together with a focus on execution excellence, we aim to expand treatment options and improve outcomes for patients with solid and haematological cancers. We’re pioneering innovative research across six scientific platforms: Tumor drivers and resistance; Immuno‑oncology, DNA damage response, Antibody drug conjugates, Epigenetics and Cell therapies.
Our ambition is to eliminate cancer as a cause of death. It’s our big vision that unites and inspires us. With multiple indications and high‑quality molecules at all stages of our innovative pipeline, we keep pushing forward. Focusing on cutting‑edge science with the latest technology to achieve breakthroughs. AZ is a place built on courage, curiosity and collaboration – we make bold decisions driven by patient outcomes.
The 2027 AZ Baselga Cancer Research Scholars cohort will join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. Working in a fast‑paced and dynamic work environment you will experience increasing levels of responsibility, following a structured learning plan in the following domains:
Specific duties and major responsibilities for the longitudinal medical project may include any of the following:
This role is open from 7th September, we welcome with your application no later than 16th October 2026.
Follow AstraZeneca on LinkedIn https://www.linkedin.com/company/1603/
Follow AstraZeneca on Facebook https://www.facebook.com/astrazenecacareers/
Follow AstraZeneca on Instagram https://www.instagram.com/astrazeneca_careers/?hl=en
AstraZenecais an equal opportunity employer that is committed to diversity and inclusion and providing a workplace that is free from discrimination. AstraZeneca is committed to accommodating persons with disabilities. Such accommodation is available on request in respect of all aspects of the recruitment, assessment and selection process and may be requested by emailingAZCHumanResources@astrazeneca.com.
Annual base salary for this position ranges from 131,520.80 to 172,621.05.
AstraZeneca is committed to providing fair and equitable compensation opportunities to all colleagues. Our compensation policies and practices have been designed to allow colleagues to progress through the salary range over time as they progress in their role. The range provided in this posting represents an offer pay range used in a majority of situations. The base pay offered will vary depending on multiple individualized factors, including the candidate's skills and experience, job‑related knowledge, and other specific business and organizational needs. In some cases, offers outside the range may also be considered to address unique circumstances.
In addition, our permanent positions offer an annual Variable Pay Bonus/Short Term Incentive opportunity as well as eligibility to participate in our equity‑based long‑term incentive program (if applicable to role). Benefits offered for permanent roles include a competitive Flex Benefits & Retirement Savings Program, 4 weeks’ paid vacation, and annual Personal Days. Fixed Term Contract/Temporary positions (excluding students) are offered a Contract Benefits Program.